Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
12/2012
12/06/2012WO2012165254A1 Ropinirole-containing adhesive skin patch and packaged product thereof
12/06/2012WO2012165253A1 Ropinirole-containing adhesive patch and packaging therefor
12/06/2012WO2012165237A1 Organopolysiloxane elastomer modified with mono-/diglycerin derivative, and use therefor
12/06/2012WO2012165235A1 Novel organopolysiloxane elastomer and use therefor
12/06/2012WO2012165233A1 Novel liquid organo polysiloxane and use therefor
12/06/2012WO2012165228A1 Novel organo polysiloxane elastomer and use therefor
12/06/2012WO2012165227A1 Production method for low-odor, sugar alcohol-modified silicone
12/06/2012WO2012164320A1 Biological system for the production of specifically biotinylated monoclonal antibodies
12/06/2012WO2012163893A1 Composition and tablet comprising raltegravir
12/06/2012WO2012163827A2 Ophthalmic preparation comprising a pgf2alpha analogue
12/06/2012WO2012163814A1 Cancer treatment by combining dna molecules mimicking double strand breaks with hyperthermia
12/06/2012WO2012163805A1 Bcma (cd269/tnfrsf17) -binding proteins
12/06/2012WO2012163665A1 Transdermal therapeutic system comprising buprenorphine and an alpha-hydroxy acid
12/06/2012WO2012163546A1 Pharmaceutical composition comprising dapagliflozin and cyclodextrin
12/06/2012WO2012163289A1 Fusion protein comprising diphtheria toxin non-toxic mutant crm197 or fragment thereof
12/06/2012WO2012162840A1 Polysaccharide-based hydrogel polymer and uses thereof
12/06/2012WO2012162807A1 Brain tumor targeting peptides and methods
12/06/2012WO2012139002A3 Anti-tumor antibody-tumor suppressor fusion protein compositions and methods of use for the treatment of cancer
12/06/2012WO2012129024A3 Compositions for encapsulating biomaterials and uses related thereto
12/06/2012WO2012106281A3 Multimodal trail molecules and uses in cellular therapies
12/06/2012WO2012091523A3 Carrier for negatively charged drugs comprising a cationic lipid and a preparation method thereof
12/06/2012WO2012079092A3 Testosterone undecanoate compositions
12/06/2012WO2011144335A8 Stable ready to use injectable paracetamol formulation
12/06/2012WO2011134084A8 Methods, compositions, and kits for the treatment of matrix mineralization disorders
12/06/2012US20120309936 Reducing the immunogenicity of fusion proteins
12/06/2012US20120309855 Low calorie, non-grain, vegan treats for companion animals
12/06/2012US20120309853 Aldohexose-based fluoroadditives
12/06/2012US20120309852 Polylactide Hydrosol and Articles Made Therefrom
12/06/2012US20120309851 Process for Reducing Residual Surface Material from Porous Polymers
12/06/2012US20120309850 Wound care device
12/06/2012US20120309836 Methods and compositions for administration of trpv1 agonists
12/06/2012US20120309823 Percutaneous absorption preparations
12/06/2012US20120309815 Compositions and methods for topical delivery of oligonucleotides
12/06/2012US20120309763 Antifungal composition intended to be applied to a perforated nail
12/06/2012US20120309761 Fast-response photochromic nanostructured contact lenses
12/06/2012US20120309748 Conjugated psychotropic drugs and uses thereof
12/06/2012US20120309720 Compositions and methods for treatment of glaucoma
12/06/2012US20120309692 Activation of Peptide Prodrugs by hK2
12/06/2012US20120309629 Alkoxylated Hyperbranched Polycarbonates for Solubilizing Poorly Soluble Active Ingredients
12/06/2012US20120309626 Hyperbranched polyester with a hydrophobic nucleus for solubilizing poorly soluble active substances
12/06/2012US20120308659 Pellet formulation for the treatment of the intenstinal tract
12/06/2012US20120308656 Sugar-coated preparation and production method for the same
12/06/2012US20120308655 Delivery Carrier
12/06/2012US20120308644 Compositions for mucosal delivery of agents
12/06/2012US20120308627 Liquid-filled protein-phosphatidic acid capsule dispersions
12/06/2012US20120308617 Phospholipid-based inhalation system
12/06/2012US20120308613 Formulations for use in inhaler devices
12/06/2012US20120308606 Bicyclic derivatives as modulators of voltage gated ion channels
12/06/2012US20120308604 Adjuvant for the preparation of vaccine compositions intended for the prevention of coccidiosis
12/06/2012US20120308532 Composition for the treatment of a bone fracture
12/06/2012US20120308494 Novel linear polydimethylsiloxane-polyether copolymers having amino and/or quaternary ammonium groups and use thereof
12/06/2012US20120308492 Foamable oil-water emulsion
12/06/2012US20120308487 Carnallite Preparation and Uses Thereof in Edible Applications
12/06/2012US20120308483 Treatment of Sleep Disturbances
12/06/2012CA2843470A1 Brain tumor targeting peptides and methods
12/06/2012CA2838237A1 Dermal filler compositions including antioxidants
12/06/2012CA2838158A1 Heterobifunctional linkers with polyethylene glycol segments and immune response modifier conjugates made therefrom
12/06/2012CA2837948A1 Formulations of recombinant furin
12/06/2012CA2837856A1 Composition for treating diabetes comprising long-acting insulin conjugate and long-acting insulinotropic peptide conjugate
12/06/2012CA2837851A1 Non-peptidyl polymer-insulin multimer and method for producing the same
12/06/2012CA2837753A1 Polysaccharide-based hydrogel polymer and uses thereof
12/06/2012CA2837710A1 Long-acting glp-1/glucagon receptor agonists
12/06/2012CA2837558A1 Modified alginates for cell encapsulation and cell therapy
12/06/2012CA2837548A1 Combined pharmaceutical compositions for the treatment of tumorous diseases
12/06/2012CA2837241A1 Composition and tablet comprising raltegravir
12/06/2012CA2837240A1 Ophthalmic preparation comprising a pgf2.alpha. analogue
12/06/2012CA2837232A1 Pharmaceutical composition comprising dapagliflozin and cyclodextrin
12/06/2012CA2837077A1 Controlled release solid dose forms
12/06/2012CA2836478A1 Therapeutic proteins with increased half-life and methods of preparing same
12/06/2012CA2834194A1 Cancer treatment by combining dna molecules mimicking double strand breaks with hyperthermia
12/06/2012CA2833820A1 Bcma (cd269/tnfrsf17) -binding proteins
12/05/2012EP2529758A2 Vitamin receptor binding drug delivery conjugates
12/05/2012EP2529757A1 Paliperidone implant formulation
12/05/2012EP2529756A2 Risperidone and/or Paliperidone implant formulation
12/05/2012EP2529755A1 Pharmaceutical composition and preparation for oral administration
12/05/2012EP2529742A1 Pharmaceutical composition comprising dapagliflozin and cyclodextrin
12/05/2012EP2529741A1 Composition and Tablet Comprising Raltegravir
12/05/2012EP2529728A1 Pharmaceutical compositions for the treatment of bacterial infections
12/05/2012EP2529628A1 A controlled-release pesticide system for a composition
12/05/2012EP2528625A1 Pyrrolobenzodiazepines and conjugates thereof
12/05/2012EP2528613A1 Method for treating liver disorders with receptor associated protein ( irp) peptide-fucosidase inhibitor conjugates
12/05/2012EP2528602A1 Formulations of bendamustine
12/05/2012EP2528594A2 Effervescent formulations comprising second generation cephalosporin
12/05/2012CN202568935U Medicinal fungus lozenge structure for inhibiting tumor
12/05/2012CN102812078A Organic/inorganic composite filler and manufacturing method therefor
12/05/2012CN102811746A Methods and compositions for nanoparticle-mediated cancer cell-targeted delivery
12/05/2012CN102811745A Liposomes containing prostaglandin e1 (pge1), formulations containing them and their use
12/05/2012CN102811744A Chemically Modified Cell-penetrating Peptides For Improved Delivery Of Gene Modulating Compounds
12/05/2012CN102811743A Stable Formulations For Lyophilizing Therapeutic Particles
12/05/2012CN102811742A Carbohydrate-polyamino acid-drug conjugates
12/05/2012CN102811741A Aqueous clear solutions of fluocinolone acetonide for treatment of otic inflammation
12/05/2012CN102811740A Adhesive complex coacervates produced from electrostatically associated block copolymers and methods for making and using the same
12/05/2012CN102811737A Pharmaceutical composition for treatment or prevention of osteoarthritis, and method of production therefor
12/05/2012CN102811724A Pharmaceutical composition having antimicrobial and fast-healing activity for external administration, process for preparing same
12/05/2012CN102811717A Nutritional composition
12/05/2012CN102811712A Solid preparation
12/05/2012CN102811708A Vesicle-containing composition
12/05/2012CN102807973A A variant form of urate oxidase and use thereof
12/05/2012CN102807677A CA-PLGA-TPGS (Cholic Acid-Poly-Lactic-co-Glycolic Acid copolymer-Tocopherol Polyethylene Glycol Succinate) star copolymer as well as preparation method and application thereof
12/05/2012CN102807657A Amphiphilic waterborne segmented copolymer medicament carrier with pH responsiveness and biodegradability and preparation thereof
1 ... 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 ... 1712